Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.
Hydration Pharmaceuticals Co. Ltd. has announced a significant change in director Adem Karafili’s interests, involving the disposal of 900,000 unlisted options due to expiration. Karafili, through Ankara Holdings Pty Ltd ATF A&N Karafili Family Trust, maintains control over 2,562,389 fully paid ordinary shares and various unlisted options with differing exercise prices and expiration dates. This change may influence investor perception and stock performance.
For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.